glp-1 drugs cancer glp 1 risk of Receptor Agonists in Breast Cancer: A New Frontier in Obesity and Prognosis Management Breaking research on GLP-1s and – The science around GLP-1 drugs

Future research should seek to gather this knowledge to help us to use -glucans to treat future patients rationally and efficiently

Battula VL, Le PM, Sun J, McQueen T, Somanchi, A, Wang RY, Strunk D, Shpall EJ, Ruvolo P, Kantarjian H, Konopleva M, Andreeff M

The signaling pathway of GLP-1R is of great significance in modulating the immune reaction of these T cells, which is closely linked to their activation, apoptosis, metabolism, and migratory capacity [16]

A previously-discussed study of miR-125b and its target IGFBP-3 in NSCLC similarly provides a sound rationale for further investigation as a prognostic test [55]